J&J says offered $2.1 billion for Lifescan diabetes business: Reuters

Johnson & Johnson (JNJ.N) said on Friday that it was offered about $2.1 billion for its LifeScan Inc unit, which makes blood glucose monitoring products, by private investment firm Platinum Equity.